期刊文献+

Ames实验及彗星实验检测辅酶NADH的抗突变作用 被引量:2

The Anti-mutagenicity of Reduced Coenzyme NADH by Ames Assay and Comet Assay
下载PDF
导出
摘要 采用Ames实验及单细胞凝胶电泳(SCGE,彗星实验),对还原型辅酶NADH进行抗突变研究。NADH中、高剂量组在加或不加S9的情况下,均能不同程度地抑制由致突变物引起的TA98、TA100回变菌落数的增加,降低SCGE拖尾细胞率。表明还原型辅酶NADH具有一定的抗突变作用。 The anti-mutagenicity of reduced coenzyme NADH was studied by Ames assay and single cell gel electrophoresis assay (SCGE, comet assay). The results showed that the the increasing of the frequency of revertant colonies caused by treating TA98, TA100 with positive mutagens could be inhibited by the middle and high dose of reduced coenzyme NADH, with or without S9. The comet assay showed that the length of DNA migration (the length of the tail of comet cells) and the percentage of migrated DNA were decreased by the middle and high dose of NADH. It indicates that the reduced coenzyme NADH might be able to inhibit mutagenesis caused by mutagens.
出处 《细胞生物学杂志》 CSCD 2005年第5期593-596,共4页 Chinese Journal of Cell Biology
基金 全军医学科研"十五"计划基金资助项目(No.01MA138)~~
关键词 AMES实验 彗星实验 辅酶NADH 抗突变作用 药物不良反应 化疗药物 细胞毒药物 reduced coenzyme NADH anti-mutagenicity Ames assay comet assay
  • 相关文献

参考文献7

二级参考文献8

  • 1[1]Zhang JR, Vreck K, Nadlinger K et al. NADH (reduced coenzyme I) rescues PC12 cells from apoptosis induced by cisplatin. J Tumor Mark Oncol, 1998, 13(3): 11
  • 2[2]Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 1983, 65(1-2):55
  • 3[3]Stecca C, Gerber GB. Adaptive response to NDA-damaging agents: a review of potential mechanisms. Biochem Pharmacol, 1998, 55(7): 941
  • 4[4]Macaya A. Apoptosis in the nervous system. Rev Neurol, 1996, 24(135):1356
  • 5[5]Lovschall H, Kassem M, Mosekilde L. Apoptosis: molecular aspects. Nord Med, 1997, 112(8):271
  • 6[6]Blagosklonny MV, Ei-Deiry WS. Acute overexpression of wt p53 facilitates anticancer drug-induced death of cancer and normal cell. Int J Cancer, 1998, 75(6):933
  • 7[7]Da-Gong W, Colin FJ, John JM et al. Expression of the apoptosis-suppressing gene bcl-2 in pheochromocytoma is associated with the expression of c-myc. J Clin Endocrinol Metab, 1997, 82 (6):1949
  • 8Carini R,Grazia M,Splendore R,et al.Sigal pathway invoved in the development of hypoxic preconditioning in rat hepatocytes[].Hepatology.2001

共引文献15

同被引文献28

  • 1BOLLAG W, HOLDENER E E. Retinoids in cancer prevention and therapy [J]. Ann Oncol, 1992,3 (7) : 513-526.
  • 2WATFENBERG L W. Prevention-therapy-basic science and the resolution of the cancer problem [ J ]. Cancer Res, 1993,53 ( 24 ) : 5890-5896.
  • 3LIPPMAN S M, BENNER S E, HONG W K. Cancer chemoprevention[J]. J Clin Oncol, 1994 12(4) :851-873.
  • 4ZHANG J R, VRECKO K, NADLINGER K, et al. The reduced coenzyme nicotinamide adenine dinucleotide (NADH) rescues PC12 cells from apoptosis[J]. J Tumor Marker Oncol, 1998,13 (3) :11-24.
  • 5DRAGANOV P, KULVACHEV Z. Molecular techniques for detection, identification and analysis of human papillomaviruses (HPVs) [ J ]. Akush Ginekol (Sofiia), 2004,43 (6) :38-44.
  • 6TAKAHASHI T. Genetic diagnosis for the infectious diseases-a nonradioactive PCR-SSCP technique [J]. Nippon Rinsho, 1999, 57(Suppl) :707-710.
  • 7MASCAUX C, IANNINO N, MARTIN B, et al. The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis [J]. Br J Cancer,2005, 92(1):131-139.
  • 8HELBIG G, HOLOWIECKI J. Ras signaling pathway as a target for farnesyhransferase inhibitors-a new, promising prospects in the treatment for malignant disorders[ J]. Wiad Lek, 2004,57 (9/ 10) :462-467.
  • 9KIM I A, FERMANDES A T, GUPTA K,et al. The influence of Ras pathway signaling on tumor radiosensitivity [ J ]. Cancer Metastasis Rev, 2004, 23 (3-4) :227-236.
  • 10BIANCO A R. Targeting c-erbB-2 and other receptors of the c-erbB family: rationale and clinical applications [ J ]. J Chemo-ther, 2004, 16(Suppt) :52-54.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部